Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta.
暂无分享,去创建一个
R. Bast | A. Berchuck | R. Whitaker | B. Arrick | G. Rodriguez | D. Clarke‐Pearson | R C Bast | A Berchuck | R Whitaker | G Olt | D L Clarke-Pearson | G Rodriguez | M P Boente | B A Arrick | M. Boente | G. Olt | G. Olt
[1] M. Korc,et al. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. , 1990, Cancer research.
[2] K. Struhl,et al. Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .
[3] R. Derynck,et al. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.
[4] M. Sporn,et al. Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer. , 1990, Immunology series.
[5] M. Sporn,et al. Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Bast,et al. The Role of Peptide Growth Factors in Epithelial Ovarian Cancer , 1990, Obstetrics and gynecology.
[7] S. Bates,et al. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. , 1989, Cancer research.
[8] R. Weinberg,et al. Tumor suppressor genes. , 1991, Science.
[9] H. Moses,et al. Isolation and characterization of kirsten murine sarcoma virus‐transformed mouse keratinocytes resistant to transforming growth factor beta , 1990, Molecular carcinogenesis.
[10] R. Bast,et al. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. , 1991, American journal of obstetrics and gynecology.
[11] R. Bast,et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.
[12] E. Adashi,et al. Ovarian transforming growth factor-β (TGFβ): cellular site(s), and mechanism(s) of action , 1989, Molecular and Cellular Endocrinology.
[13] A. Brunner,et al. Transforming growth factor beta 1: importance of glycosylation and acidic proteases for processing and secretion. , 1989, Molecular endocrinology.
[14] P. Kruk,et al. A simplified method to culture human ovarian surface epithelium. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[15] A. Brunner,et al. Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells , 1987, Molecular and cellular biology.
[16] H. Moses,et al. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.
[17] F. Hahn,et al. Increased resistance to transforming growth factor beta accompanies neoplastic progression of rat tracheal epithelial cells. , 1989, Carcinogenesis.
[18] K. Osteen,et al. Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. , 1987, Endocrinology.
[19] D. Danielpour,et al. Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2, but only type 2 is regulated by gonadotropin in vitro. , 1991, Endocrinology.
[20] N. Auersperg,et al. Serial propagation of human ovarian surface epithelium in tissue culture , 1988, Journal of cellular physiology.
[21] Inae Kim,et al. The production of transforming growth factor-beta activity by rat granulosa cell cultures. , 1989, Endocrinology.
[22] R. Bast,et al. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor , 1991, American journal of obstetrics and gynecology.
[23] M. Sporn,et al. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Dasch,et al. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. , 1989, Journal of immunology.
[25] G. Sato,et al. Growth of a human mammary tumour cell line in a serum-free medium , 1979, Nature.
[26] D. Lawrence,et al. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. , 1984, Cancer research.
[27] C. Daniel,et al. Reversible inhibition of mammary gland growth by transforming growth factor-beta. , 1987, Science.
[28] M. O’Connor-McCourt,et al. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.
[29] V. Band,et al. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. , 1988, Cancer research.